CAI (Caris Life Sciences) Marketable Securities: $2.3 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI Caris Life Sciences Inc CAI
11 GF Score
Price $15.53
! 2 Warning Signs
View Full Analysis

What is Caris Life Sciences Marketable Securities?

Caris Life Sciences CAI -0.89% 11 Marketable Securities is $2.3 Mil as of Mar. 2026. GuruFocus rates CAI with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Caris Life Sciences's Marketable Securities for the quarter that ended in Mar. 2026 was $2.3 Mil.

Caris Life Sciences's annual Marketable Securities declined from Dec. 2023 ($65.2 Mil) to Dec. 2024 ($2.2 Mil) but then increased from Dec. 2024 ($2.2 Mil) to Dec. 2025 ($2.3 Mil).

Caris Life Sciences  (NAS:CAI) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Caris Life Sciences Marketable Securities Related Terms

Caris Life Sciences Marketable Securities Historical Data

* Premium members only.

The historical data trend for Caris Life Sciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caris Life Sciences Marketable Securities Chart

Caris Life Sciences Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Marketable Securities
302.43 65.18 2.20 2.30

Caris Life Sciences Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.23 2.25 2.27 2.30 2.32
CAI
11GF Score
Caris Life Sciences Inc CAI
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Caris Life Sciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $2.3 Mil mean?
Caris Life Sciences (CAI) has a Marketable Securities of $2.3 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Caris Life Sciences and its competitors.
Is Caris Life Sciences' Marketable Securities too high?
Caris Life Sciences' current Marketable Securities is $2.3 Mil. Overall, Caris Life Sciences has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Caris Life Sciences' Marketable Securities compare to DNTH and MANE?
Caris Life Sciences' Marketable Securities of $2.3 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Caris Life Sciences and its competitors. Caris Life Sciences's current Marketable Securities is $2.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caris Life Sciences stock overvalued right now?
Caris Life Sciences (CAI) has a current Marketable Securities of $2.3 Mil. The current Marketable Securities is $2.3 Mil. Caris Life Sciences' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Caris Life Sciences (CAI), the current Marketable Securities is $2.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Caris Life Sciences Business Description

Other Exchanges CAI:Mexico49J:Germany
Address 750 W. John Carpenter Freeway, Suite 800, Irving, TX, USA, 75039
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
11GF Score

Get the complete analysis for CAI

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.53
Price